刘芮闻 六年制（2022-2024）

 

E-mail: 1810307114@pku.edu.cn

毕业去向：

重庆圣华曦药业股份有限公司

教育经历：

2018.9 - 2022.6 北京大学医学部 药学院 学士

2022.9 - 2024.7 北京大学医学部 药学院 硕士

研究领域：

抗流感病毒药物的研究

研究成果：

1. Zhu X.,# Liu R.,# Yi Y., Hua L., Tretyakova E.V.*, Zhang Y., Zhou D., Xiao S.* Click chemistry can access unnatural N-acetylneuraminic acid–anchored β-cyclodextrin conjugates as potential anti-SARS-CoV-2 entry inhibitors. Tetrahedron Letters. 2024, 140, 155047.

2. Zhu X., Yi Y., Fan Z., Liu R., Chu X., Wang M., Zhang J., Tretyakova E., Zhang Y., Zhang L., Zhou D., Xiao S.* Novel mono- and multivalent N-acetylneuraminic acid glycoclusters as potential broad-spectrum entry inhibitors for influenza and coronavirus infection. European Journal of Medicinal Chemistry. 2023, 260, 115723.

3. Cheng B., Chu X., Liu R., Ma X., Wang M., Zhang J., Jiao P., Gao Q., Ma W., Zhang Y., Zhao C.*, Zhou D., Xiao S.* Synthesis of novel pentacyclic triterpenoid derivatives that induce apoptosis in cancer cells through a ROS-dependent, mitochondrial-mediated pathway. Molecular Pharmaceutics. 2023, 20(1), 701-710.

4. Yi Y., Ma X., Liu R., Chu X., Li H., Zhang J., Gao Q., Zhang Y., Zhang L., Zhou D., Xiao S.* An attempt to synthesize the two monomers of CDTOH: unexpected NMR and X-ray diffraction crystal analysis. Tetrahedron Letters. 2022, 91, 153638.

毕业感言：

感谢北大，感谢Zhou Lab，感谢各位老师、同仁。

座右铭：

执炬迎风，踏浪而行。

精彩花絮：